{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:43:29Z","timestamp":1792734209786,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"17-18","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.drudis.2009.06.009","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T05:44:09Z","timestamp":1246599849000},"page":"866-875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":165,"title":["The complexity of the GABAA receptor shapes unique pharmacological profiles"],"prefix":"10.1016","volume":"14","author":[{"given":"Charlotte","family":"D\u2019Hulst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Atack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Frank","family":"Kooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2009.06.009_bib1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1152\/jn.00317.2003","article-title":"Dynamic equilibrium of neurotransmitter transporters: not just for reuptake anymore","volume":"90","author":"Richerson","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.drudis.2009.06.009_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tins.2007.06.003","article-title":"The GABA(A) receptor: a novel target for treatment of fragile X?","volume":"30","author":"D\u2019Hulst","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib3","unstructured":"Purves, D. et al. (1997) Department of Neurobiology, Dale University Medical Centre, Sinauer Associates, Sunderland, Massachusetts, Neuroscience"},{"key":"10.1016\/j.drudis.2009.06.009_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1046\/j.1471-4159.1994.62020815.x","article-title":"Quaternary structure of the native GABAA receptor determined by electron microscopic image analysis","volume":"62","author":"Nayeem","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drudis.2009.06.009_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drudis.2009.06.009_bib6","doi-asserted-by":"crossref","first-page":"41422","DOI":"10.1074\/jbc.M401354200","article-title":"Analysis of the set of GABA(A) receptor genes in the human genome","volume":"279","author":"Simon","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2009.06.009_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0165-6147(99)01413-3","article-title":"The \u2018ABC\u2019 of GABA receptors","volume":"21","author":"Bormann","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drudis.2009.06.009_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1568026023393507","article-title":"Subunit composition, distribution and function of GABA(A) receptor subtypes","volume":"2","author":"Sieghart","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.drudis.2009.06.009_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-2236(96)80023-3","article-title":"Which GABAA-receptor subtypes really occur in the brain?","volume":"19","author":"McKernan","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1042\/BST0340868","article-title":"Impact of subunit positioning on GABAA receptor function","volume":"34","author":"Sigel","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.drudis.2009.06.009_bib11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tips.2004.07.005","article-title":"Techniques: use of concatenated subunits for the study of ligand-gated ion channels","volume":"25","author":"Minier","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drudis.2009.06.009_bib12","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1046\/j.1471-4159.1994.63041466.x","article-title":"Short and long form gamma 2 subunits of the GABAA\/benzodiazepine receptors","volume":"63","author":"Khan","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drudis.2009.06.009_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/mcne.2000.0856","article-title":"Long-range interactions in neuronal gene expression: evidence from gene targeting in the GABA(A) receptor beta2-alpha6-alpha1-gamma2 subunit gene cluster","volume":"16","author":"Uusi-Oukari","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0922-4106(95)00061-5","article-title":"Characterisation of delta-subunit containing GABAA receptors from rat brain","volume":"290","author":"Quirk","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drudis.2009.06.009_bib15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0306-4522(01)00527-9","article-title":"Altered receptor subtypes in the forebrain of GABAA receptor delta subunit-deficient mice: recruitment of gamma 2 subunits","volume":"109","author":"Korpi","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.drudis.2009.06.009_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cne.10210","article-title":"GABA(A) receptor changes in delta subunit-deficient mice: altered expression of alpha4 and gamma2 subunits in the forebrain","volume":"446","author":"Peng","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.drudis.2009.06.009_bib17","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1523\/JNEUROSCI.12-03-01040.1992","article-title":"The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon","volume":"12","author":"Wisden","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","article-title":"GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain","volume":"101","author":"Pirker","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.drudis.2009.06.009_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrn2370","article-title":"GABAA receptor trafficking and its role in the dynamic modulation of neuronal inhibition","volume":"9","author":"Jacob","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1523\/JNEUROSCI.4011-04.2005","article-title":"Distinct gamma2 subunit domains mediate clustering and synaptic function of postsynaptic GABAA receptors and gephyrin","volume":"25","author":"Alldred","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0163-7258(03)00037-8","article-title":"Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications","volume":"98","author":"Fritschy","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2009.06.009_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tins.2004.03.005","article-title":"Tonically active GABAA receptors: modulating gain and maintaining the tone","volume":"27","author":"Semyanov","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib23","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1523\/JNEUROSCI.18-05-01693.1998","article-title":"Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells","volume":"18","author":"Nusser","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bjp.0704795","article-title":"Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors","volume":"136","author":"Brown","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2009.06.009_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pharmthera.2004.06.001","article-title":"Genetic manipulations of GABAA receptor in mice make inhibition exciting","volume":"103","author":"Vicini","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2009.06.009_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.300.1.2","article-title":"A new benzodiazepine pharmacology","volume":"300","author":"Mohler","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2009.06.009_bib28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.pharmtox.44.101802.121429","article-title":"Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics","volume":"44","author":"Rudolph","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.drudis.2009.06.009_bib29","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0021-9258(18)45961-3","article-title":"A single histidine in GABAA receptors is essential for benzodiazepine agonist binding","volume":"267","author":"Wieland","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2009.06.009_bib30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0014-5793(98)00803-5","article-title":"Pharmacology of recombinant gamma-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated alpha-subunits","volume":"431","author":"Benson","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drudis.2009.06.009_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1096\/fj.02-0611fje","article-title":"General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit","volume":"17","author":"Jurd","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.drudis.2009.06.009_bib32","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1523\/JNEUROSCI.23-24-08608.2003","article-title":"Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms","volume":"23","author":"Reynolds","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0301-0082(02)00013-8","article-title":"Drug interactions at GABA(A) receptors","volume":"67","author":"Korpi","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.drudis.2009.06.009_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0031-6997(25)06840-1","article-title":"Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes","volume":"47","author":"Sieghart","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drudis.2009.06.009_bib35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0165-6147(00)89009-4","article-title":"Functional domains of GABAA receptors","volume":"16","author":"Smith","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drudis.2009.06.009_bib36","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1124\/mol.52.6.1150","article-title":"Differences in agonist\/antagonist binding affinity and receptor transduction using recombinant human gamma-aminobutyric acid type A receptors","volume":"52","author":"Ebert","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drudis.2009.06.009_bib37","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1124\/jpet.105.092403","article-title":"Pharmacological characterization of agonists at delta-containing GABAA receptors: functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2","volume":"316","author":"Storustovu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2009.06.009_bib38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coph.2005.10.004","article-title":"Gaboxadol\u2014a new awakening in sleep","volume":"6","author":"Wafford","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.drudis.2009.06.009_bib40","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1460-9568.2009.06680.x","article-title":"Inhibition of thalamic excitability by 4,5,6,7-tetrahydroisoxazolo4,5-cpyridine-3-ol: a selective role for delta-GABA(A) receptors","volume":"29","author":"Herd","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib41","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1523\/JNEUROSCI.2679-05.2005","article-title":"Extrasynaptic GABAA receptors of thalamocortical neurons: a molecular target for hypnotics","volume":"25","author":"Belelli","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib42","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.bcp.2004.06.039","article-title":"GABA pharmacology\u2014what prospects for the future?","volume":"68","author":"Iversen","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2009.06.009_bib43","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.ne.17.030194.003033","article-title":"GABAA receptor channels","volume":"17","author":"Macdonald","year":"1994","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1054-3589(06)54010-4","article-title":"Structure, pharmacology, and function of GABAA receptor subtypes","volume":"54","author":"Sieghart","year":"2006","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.drudis.2009.06.009_bib45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor \u03b11 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"Low","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.drudis.2009.06.009_bib47","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","article-title":"Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor","volume":"22","author":"Collinson","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/bdd.423","article-title":"Rodent pharmacokinetics and receptor occupancy of the GABAA receptor subtype selective benzodiazepine site ligand L-838417","volume":"26","author":"Scott-Stevens","year":"2005","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.drudis.2009.06.009_bib49","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.105.089920","article-title":"TPA023 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluor ophenyl)-1,2,4-triazolo4,3-bpyridazine, an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates","volume":"316","author":"Atack","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2009.06.009_bib50","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.108.138859","article-title":"NS11394 3\u2019-5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl-biphenyl-2-carbonitr ile, a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy","volume":"327","author":"Mirza","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2009.06.009_bib51","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1517\/13543784.14.5.601","article-title":"The benzodiazepine binding site of GABAA receptors as a target for the development of novel anxiolytics","volume":"14","author":"Atack","year":"2005","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.drudis.2009.06.009_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/S1092852900009883","article-title":"Contributions of GABAA receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders","volume":"10","author":"Ator","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.drudis.2009.06.009_bib53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0269881107082108","article-title":"Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers","volume":"22","author":"de Haas","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drudis.2009.06.009_bib54","doi-asserted-by":"crossref","first-page":"17154","DOI":"10.1073\/pnas.0508752102","article-title":"A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction","volume":"102","author":"Yee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2009.06.009_bib55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2005.10.003","article-title":"GABA-based therapeutic approaches: GABAA receptor subtype functions","volume":"6","author":"Rudolph","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.drudis.2009.06.009_bib56","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/appi.ajp.2008.08030395","article-title":"Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia","volume":"165","author":"Lewis","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drudis.2009.06.009_bib57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(83)90076-4","article-title":"Severe anxiety induced by FG, 7142, a beta-carboline ligand for benzodiazepine receptors","volume":"2","author":"Dorow","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2009.06.009_bib58","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/1568007033482779","article-title":"GABA(A) receptor subtype selective cognition enhancers","volume":"2","author":"Maubach","year":"2003","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.drudis.2009.06.009_bib59","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuropharm.2006.04.018","article-title":"L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors","volume":"51","author":"Atack","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drudis.2009.06.009_bib60","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/jm031076j","article-title":"Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancers","volume":"47","author":"Sternfeld","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2009.06.009_bib61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-008-1357-7","article-title":"RO4938581, a novel cognitive enhancer acting at GABA(A) alpha5 subunit-containing receptors","volume":"202","author":"Ballard","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drudis.2009.06.009_bib62","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1124\/jpet.105.092320","article-title":"An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition","volume":"316","author":"Dawson","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2009.06.009_bib63","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.neuropharm.2007.08.008","article-title":"Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist","volume":"53","author":"Nutt","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drudis.2009.06.009_bib64","doi-asserted-by":"crossref","first-page":"12905","DOI":"10.1073\/pnas.96.22.12905","article-title":"Attenuated sensitivity to neuroactive steroids in \u03b3-aminobutyrate type A receptor delta subunit knockout mice","volume":"96","author":"Mihalek","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2009.06.009_bib65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nurt.2006.11.003","article-title":"Ganaxolone","volume":"4","author":"Nohria","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.drudis.2009.06.009_bib66","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.bjp.0707186","article-title":"Characterization of 35St-butylbicyclophosphorothionate (35STBPS) binding to GABAA receptors in postmortem human brain","volume":"150","author":"Atack","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2009.06.009_bib67","doi-asserted-by":"crossref","first-page":"15218","DOI":"10.1073\/pnas.2435171100","article-title":"Ethanol enhances alpha 4 beta 3 delta and alpha 6 beta 3 delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans","volume":"100","author":"Wallner","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2009.06.009_bib68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.alcohol.2007.04.006","article-title":"GABAA receptor subtypes: the \u2018one glass of wine\u2019 receptors","volume":"41","author":"Olsen","year":"2007","journal-title":"Alcohol"},{"key":"10.1016\/j.drudis.2009.06.009_bib69","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/bjp.2008.32","article-title":"Physiology and pharmacology of alcohol: the imidazobenzodiazepine alcohol antagonist site on subtypes of GABAA receptors as an opportunity for drug development?","volume":"154","author":"Wallner","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2009.06.009_bib70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/35051086","article-title":"Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance","volume":"409","author":"Brickley","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2009.06.009_bib71","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.0307231101","article-title":"Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors","volume":"101","author":"Caraiscos","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2009.06.009_bib72","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2009.06.009_bib73","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/12207","article-title":"Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues","volume":"2","author":"Crestani","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib74","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/2798","article-title":"Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin","volume":"1","author":"Essrich","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib75","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1073\/pnas.92.17.7749","article-title":"Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors","volume":"92","author":"Gunther","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2009.06.009_bib76","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1073\/pnas.94.8.4143","article-title":"Mice devoid of \u03b3-aminobutyrate type A receptor \u03b23 subunit have epilepsy, cleft palate, and hypersensitive behavior","volume":"94","author":"Homanics","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2009.06.009_bib77","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1523\/JNEUROSCI.17-04-01350.1997","article-title":"Ligand-gated ion channel subunit partnerships: GABAA receptor alpha6 subunit gene inactivation inhibits delta subunit expression","volume":"17","author":"Jones","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib78","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1460-9568.1999.00421.x","article-title":"Cerebellar granule-cell-specific GABAA receptors attenuate benzodiazepine-induced ataxia: evidence from alpha 6-subunit-deficient mice","volume":"11","author":"Korpi","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib79","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0028-3908(02)00174-0","article-title":"GABA(A) receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem","volume":"43","author":"Kralic","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drudis.2009.06.009_bib80","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety.","volume":"290","author":"Low","year":"2000","journal-title":"Science (New York, NY"},{"key":"10.1016\/j.drudis.2009.06.009_bib81","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1523\/JNEUROSCI.22-10-04163.2002","article-title":"Elimination of the rho1 subunit abolishes GABA(C) receptor expression and alters visual processing in the mouse retina","volume":"22","author":"McCall","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib82","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2009.06.009_bib83","doi-asserted-by":"crossref","first-page":"14439","DOI":"10.1073\/pnas.2435457100","article-title":"Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors","volume":"100","author":"Stell","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2009.06.009_bib84","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1523\/JNEUROSCI.21-10-03409.2001","article-title":"Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice","volume":"21","author":"Sur","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib85","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1523\/JNEUROSCI.21-09-03009.2001","article-title":"GABA(A) receptor alpha1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons","volume":"21","author":"Vicini","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib86","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0026-895X(24)12233-X","volume":"59","author":"Crestani","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drudis.2009.06.009_bib87","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nn1398","article-title":"Alcohol-induced motor impairment caused by increased extrasynaptic GABA(A) receptor activity","volume":"8","author":"Hanchar","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drudis.2009.06.009_bib88","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/361356a0","article-title":"Benzodiazepine-induced motor impairment linked to point mutation in cerebellar GABAA receptor","volume":"361","author":"Korpi","year":"1993","journal-title":"Nature"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644609002177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644609002177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:05:13Z","timestamp":1761221113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644609002177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":88,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1359644609002177"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2009.06.009","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The complexity of the GABAA receptor shapes unique pharmacological profiles","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2009.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}